Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study.
Engelen MM, Van Thillo Q, Betrains A, Gyselinck I, Martens CP, Spalart V, Ockerman A, Devooght C, Wauters J, Gunst J, Wouters C, Vandenbriele C, Rex S, Liesenborghs L, Wilmer A, Meersseman P, Van den Berghe G, Dauwe D, Belmans A, Thomeer M, Fivez T, Mesotten D, Ruttens D, Heytens L, Dapper I, Tuyls S, De Tavernier B, Verhamme P, Vanassche T; DAWn Consortium Members.
Engelen MM, et al. Among authors: wilmer a.
Res Pract Thromb Haemost. 2022 Oct 30;6(7):e12826. doi: 10.1002/rth2.12826. eCollection 2022 Oct.
Res Pract Thromb Haemost. 2022.
PMID: 36324831
Free PMC article.